Regulatory Pharma Net
Regulatory Pharma Net is an Italian regulatory affairs and market access consultancy serving pharmaceutical, biotech, and MedTech companies across the EU, US, and UK via eight service lines including an AI lab and training academy.
- Company typePrivate
- Founded1999
- HeadquartersPisa, Italy
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Regulatory Pharma Net does
Regulatory Pharma Net SRL is an Italian-headquartered (Pisa) regulatory affairs and market access consultancy founded in 1999, operating as a private Società a responsabilità limitata with a nominal corporation stock of €60,000 and a headcount in the 11-50 range. The firm serves pharmaceutical, biotechnology, and medical technology companies, alongside non-EU firms entering the European market and companies targeting the US and UK, providing strategic, in-market, and executional support across the entire product life cycle. Its portfolio is organized into eight service lines: Pharmaceutical & BioTech, MedTech, EU Roadmap for Non-EU Companies, USA Specific Solutions, UK Specific Solutions, RPN Academy (training), Quality & Compliance, and the RPN AI Lab (AI innovation).
The business operates a B2B sales-led professional services model. Engagements are quote-based and tailored, initiated through structured email inquiries across five service categories (Drug Development, Regulatory Affairs, Market Access, Advertising & Promotion, Other) and direct expert consultations. Go-to-market is reinforced by content marketing via an Insights & Publications section, a corporate LinkedIn presence, and consistent participation in industry events including MAPS EMEA, DIA Europe, World EPA Congress, and ISPOR Europe and ISPOR Italy conferences. Founder and managing director Anita Falezza anchors the firm, which markets over 25 years of combined expertise and international certifications as its primary differentiator against larger CROs and pure-play consultancies.
Underlying technology is primarily human-expert delivery augmented by a nascent RPN AI Lab aimed at applying AI to regulatory and market access processes; no proprietary AI models, patents, or benchmarks are disclosed. The firm has no external investors, no parent company, no funding rounds, and no disclosed revenue, with a stated operating geography spanning Italy, Switzerland, the Netherlands, the UK, and the USA. Customers, pricing, and contract values are not publicly disclosed.
Regulatory Pharma Net firmographics
Firmographics- Name
- Regulatory Pharma Net
- Legal name
- Regulatory Pharma Net SRL
- Website
- https://regulatorypharmanet.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Regulatory Pharma Net is an Italian regulatory affairs and market access consultancy serving pharmaceutical, biotech, and MedTech companies across the EU, US, and UK via eight service lines including an AI lab and training academy.
- Ownership category
- akta.pro rank
Regulatory Pharma Net industry classification
Industry- Product category
- Pharmaceutical Regulatory Affairs Consulting
- akta.pro primary industry
- Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC)
Keywords
Where Regulatory Pharma Net is headquartered
LocationHeadquarters
- HQ city
- Pisa
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Regulatory Pharma Net business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Regulatory Affairs & Market Access Consulting: Professional consulting services providing end-to-end support for pharmaceutical and life science companies throughout the product lifecycle. Services include regulatory affairs strategy, market access planning, and executional expertise across international markets.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Regulatory Pharma Net product offering
Product offeringCore offering
Regulatory Pharma Net is a consulting firm that delivers regulatory affairs and market access services to pharmaceutical, biotechnology, and medical device companies. It sells end-to-end strategic, in-market, and executional expertise across the entire product life cycle and across international markets (EU, USA, UK), with a one-stop-shop portfolio of eight service lines spanning pharma/biotech, medtech, regional market entry, training, quality & compliance, and an AI innovation lab.
Product overview
Regulatory Pharma Net operates as a service-based consultancy offering an integrated portfolio of regulatory affairs and market access solutions for the pharmaceutical, biotech, and medtech industries. The portfolio is organized into eight distinct service offerings: Pharmaceutical & BioTech Services, Medtech Services, EU Roadmap for Non-EU Companies, USA Specific Solutions, UK Specific Solutions, RPN Academy (training), Quality & Compliance, and RPN AI Lab (AI innovation). These services are designed to work together seamlessly, providing end-to-end support throughout the entire product life cycle and across international markets, with over 25 years of combined expertise.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical & BioTech Services
Companies that use Regulatory Pharma Net
Customer profileSegments5 records
Ideal customer profiles1 record
Regulatory Pharma Net technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature1 record
Regulatory Pharma Net partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor.
- Medical Affairs Professional Society (MAPS)minorRPN participates as an attendee/exhibitor at the MAPS EMEA Annual Meeting 2026 in Zurich, Switzerland. This represents professional association membership and event participation in the medical affairs community.
- DIA EuropeminorRPN participates at DIA Europe 2026 conference in Rotterdam. DIA is a global organization providing education and networking for health professionals involved in the discovery, development, and lifecycle management of healthcare products.
- World EPA CongressminorRPN participates at the World EPA Congress 2026 in Amsterdam, focusing on health economics and outcomes research, pricing, and market access.
- ISPOR (International Society for Pharmacoeconomics and Outcomes Research)minorRPN participates in ISPOR events including ISPOR Europe 2025 in Glasgow and the ISPOR Italy Rome Chapter 2025 conference, demonstrating involvement in pharmacoeconomics and outcomes research community.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Regulatory Pharma Net competitors and assessment
Company assessmentDirect peers
- NDA Group: European regulatory affairs and market access advisory serving drug and device developers, directly comparable to RPN's strategic regulatory consulting.
- Arriello: Boutique-to-mid European provider of regulatory affairs, pharmacovigilance, and quality/compliance services, similar in scope and client base to RPN.
- Voisin Consulting Life Sciences: Regulatory and product development consultancy guiding pharma, biotech, and medtech through EU and US approval and market access, aligning with RPN's advisory positioning.
- Diamond Pharma Services: European regulatory affairs and market access consultancy supporting product lifecycle and EU market entry, closely matching RPN's service mix.
- Qserve Group: Specialist medtech regulatory and quality consultancy covering EU MDR and US FDA, overlapping with RPN's Medtech and Quality & Compliance service lines.
- ProductLife Group: European regulatory affairs, market access, and compliance consultancy for life sciences companies, closely comparable to RPN's integrated end-to-end service portfolio.
- Freyr Solutions: Specialized regulatory affairs and compliance services firm serving pharma, biotech, and medtech across EU/US/UK, mirroring RPN's multi-jurisdiction consulting model.
Broad incumbents
- PharmaLex: Global provider of regulatory affairs, pharmacovigilance, and market access services to pharma and medtech; directly overlaps with RPN's core offering but at far larger scale and footprint.
Emerging players
- Boyds: UK-based product development and regulatory affairs consultancy for pharma and biotech, comparable to RPN's lifecycle advisory and UK-specific solutions.
Regional players
- Real Regulatory: Ireland-based regulatory affairs and quality consultancy for pharma and medtech serving European market access, similar niche to RPN but focused on a different geography.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Regulatory Pharma Net social profiles
Digital presenceRegulatory Pharma Net financial estimates
Financial estimateRevenue estimate
Valuation estimate
Regulatory Pharma Net leadership team
Management profileNumber of profiles
Profiles1 record
Regulatory Pharma Net funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Regulatory Pharma Net M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Regulatory Pharma Net
What does Regulatory Pharma Net do?
Regulatory Pharma Net is a consulting firm that delivers regulatory affairs and market access services to pharmaceutical, biotechnology, and medical device companies. It sells end-to-end strategic, in-market, and executional expertise across the entire product life cycle and across international markets (EU, USA, UK), with a one-stop-shop portfolio of eight service lines spanning pharma/biotech, medtech, regional market entry, training, quality & compliance, and an AI innovation lab.
Is Regulatory Pharma Net a public or private company?
Regulatory Pharma Net is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Regulatory Pharma Net founded?
Regulatory Pharma Net was founded in 1999. It employs 11 to 50 people.
Where is Regulatory Pharma Net based?
Regulatory Pharma Net is headquartered in Pisa, Italy, in the Europe region.
How does Regulatory Pharma Net make money?
One revenue line is on record: regulatory Affairs & Market Access Consulting.
Who are Regulatory Pharma Net's main competitors?
Direct peers on record are NDA Group, Arriello, Voisin Consulting Life Sciences, Diamond Pharma Services, Qserve Group, ProductLife Group and Freyr Solutions. PharmaLex is listed as a broad incumbent. Boyds is listed as an emerging player. Real Regulatory is listed as a regional player.
Does Regulatory Pharma Net have an API?
No public API is recorded for Regulatory Pharma Net.
What industry is Regulatory Pharma Net in?
Regulatory Pharma Net's product category is Pharmaceutical Regulatory Affairs Consulting. Its primary akta.pro industry code is HLAGAKAC, Regulatory Operations & Publishing (eCTD, RIM, Submission Management).